These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 17541422)

  • 1. RNAi-mediated knockdown of target genes: a promising strategy for pancreatic cancer research.
    Chang H
    Cancer Gene Ther; 2007 Aug; 14(8):677-85. PubMed ID: 17541422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA interference: implications for cancer treatment.
    Masiero M; Nardo G; Indraccolo S; Favaro E
    Mol Aspects Med; 2007 Feb; 28(1):143-66. PubMed ID: 17307250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting XIAP bypasses Bcl-2-mediated resistance to TRAIL and cooperates with TRAIL to suppress pancreatic cancer growth in vitro and in vivo.
    Vogler M; Walczak H; Stadel D; Haas TL; Genze F; Jovanovic M; Gschwend JE; Simmet T; Debatin KM; Fulda S
    Cancer Res; 2008 Oct; 68(19):7956-65. PubMed ID: 18829553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospects of RNA interference therapy for cancer.
    Pai SI; Lin YY; Macaes B; Meneshian A; Hung CF; Wu TC
    Gene Ther; 2006 Mar; 13(6):464-77. PubMed ID: 16341059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA interference: a practical approach.
    Duxbury MS; Whang EE
    J Surg Res; 2004 Apr; 117(2):339-44. PubMed ID: 15047140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA interference technologies and their use in cancer research.
    Gaither A; Iourgenko V
    Curr Opin Oncol; 2007 Jan; 19(1):50-4. PubMed ID: 17133112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene therapy developments for pancreatic cancer.
    Bhattacharyya M; Lemoine NR
    Best Pract Res Clin Gastroenterol; 2006 Apr; 20(2):285-98. PubMed ID: 16549328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of RNAi-mediated STAT3 gene inhibition on metastasis of human pancreatic cancer cells].
    Gao Z; Huang C; Qiu ZJ; Jiang T; Zhu L; Cao J; Zhang F; Huang KJ
    Zhonghua Wai Ke Za Zhi; 2008 Jul; 46(13):1010-3. PubMed ID: 19035205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNAi therapy for neurodegenerative diseases.
    Boudreau RL; Davidson BL
    Curr Top Dev Biol; 2006; 75():73-92. PubMed ID: 16984810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lentivirus-mediated short hairpin RNA targeting the APRIL gene suppresses the growth of pancreatic cancer cells in vitro and in vivo.
    Wang F; Chen L; Mao ZB; Shao JG; Tan C; Huang WD
    Oncol Rep; 2008 Jul; 20(1):135-9. PubMed ID: 18575728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting of CDC20 via small interfering RNA causes enhancement of the cytotoxicity of chemoradiation.
    Taniguchi K; Momiyama N; Ueda M; Matsuyama R; Mori R; Fujii Y; Ichikawa Y; Endo I; Togo S; Shimada H
    Anticancer Res; 2008; 28(3A):1559-63. PubMed ID: 18630511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA interference as a novel and powerful tool in immunopharmacological research.
    Kong Y; Ruan L; Ma L; Cui Y; Wang JM; Le Y
    Int Immunopharmacol; 2007 Apr; 7(4):417-26. PubMed ID: 17321464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53.
    Sima N; Wang W; Kong D; Deng D; Xu Q; Zhou J; Xu G; Meng L; Lu Y; Wang S; Ma D
    Apoptosis; 2008 Feb; 13(2):273-81. PubMed ID: 18060502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinoic acid receptor antagonists inhibit miR-10a expression and block metastatic behavior of pancreatic cancer.
    Weiss FU; Marques IJ; Woltering JM; Vlecken DH; Aghdassi A; Partecke LI; Heidecke CD; Lerch MM; Bagowski CP
    Gastroenterology; 2009 Dec; 137(6):2136-45.e1-7. PubMed ID: 19747919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic antitumor activity of XIAP-shRNA and TRAIL expressed by oncolytic adenoviruses in experimental HCC.
    Pan Q; Liu B; Liu J; Cai R; Liu X; Qian C
    Acta Oncol; 2008; 47(1):135-44. PubMed ID: 17934893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic RNA interference for neurodegenerative diseases: From promise to progress.
    Gonzalez-Alegre P
    Pharmacol Ther; 2007 Apr; 114(1):34-55. PubMed ID: 17316816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA interference screening for the discovery of oncology targets.
    Quon K; Kassner PD
    Expert Opin Ther Targets; 2009 Sep; 13(9):1027-35. PubMed ID: 19650760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA interference-mediated validation of genes involved in telomere maintenance and evasion of apoptosis as cancer therapeutic targets.
    Folini M; Pennati M; Zaffaroni N
    Methods Mol Biol; 2009; 487():303-30. PubMed ID: 19301654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA interference: emerging diagnostics and therapeutics tool.
    Shrey K; Suchit A; Nishant M; Vibha R
    Biochem Biophys Res Commun; 2009 Aug; 386(2):273-7. PubMed ID: 19523438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using RNAi to catch Drosophila genes in a web of interactions: insights into cancer research.
    Dasgupta R; Perrimon N
    Oncogene; 2004 Nov; 23(51):8359-65. PubMed ID: 15517017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.